Biotechnology Information Institute

Biotechnology Information Institute

The Biotechnology Information Institute (BII) develops unique, high-end information resources and provides consulting serving critical needs of the biotechnology and pharmaceutical communities. As a sole proprietorship, Ronald A. Rader, President, is responsible for all of BII's products. Current, former and upcoming publications include:

BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets: the only biopharmaceutical products reference (8th edition now online)
Biopharmaceutical Expression Systems and Genetic Engineering Technologies: Current and Future Manufacturing Platforms: the only directory of expression systems, cell lines, vectors/plasmids and other genetic engineering technologies (Oct. 2008)
Antiviral Agents Bulletin: for 15 years (1987-2003) the only periodical specializing in antiviral drug and vaccine development (over 5,700 pages) [former]
Federal Bio-Technology Transfer Directory: all federal, e.g., NIH, inventions and technology transfers in the biomedical/biotechnology areas (687-page book in 1994; online database to 2000) [former]
U.S. BIOPHARMACOPEIA™ Registry of Biopharmaceuticals Products: nomenclature and an online registry of biopharmaceuticals, including biosimilars/biogenerics [planned]
Biosimilars/Follow-on Proteins: Web site with in-depth about these products, also news and analysis [planned]

Further information about these is presented below.

BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets

The only reference (database, formerly multi-volume book) concerning biopharmaceutical products
Emphasis on products' biotechnology and commerical aspects
In-depth descriptive and analytical monographs, with in-depth indexing and relational links
Free online public database (partial entries)
Recognized as the essential reference for all concerned with biopharmaceuticals - See the reviews.
Individual and corporate Web database subsccriptions available at reasonable rates

Coming! New additions to the BIOPHARMA® suite of information resources:
U.S. BIOPHARMACOPEIA™ Registry of Biopharmaceuticals
Generic BIOPHARMA: Biogenerics, Biosimilars, Follow-on Biologics/Proteins...

Earlier works authored by R. Rader and published by the Biotechnology Information Institute:

Antiviral Agents Bulletin

- from April 1988 to March 2003

For 15 years, the Antiviral Agents Bulletin was the only periodical specializing in the research, development and commercialization of antiviral and HIV therapeutics and vaccines. Published monthly, 32 pages/issue, each year the Bulletin presented over 400 in-depth news articles plus hundreds of U.S patents and international patent disclosures and other information, with in-depth annual indexes and reviews.

Federal Bio-Technology Transfer Directory - 678-page book published in 1994; online database until early 2000

Abstracted/indexed all federal laboratory (e.g., NIH) patents/applications, licenses granted and Collaborative Research and Development Agreements (CRADAs) in the biomedical, biotechnology and pharmaceutical areas.

Consulting: The Biotechnology Information Institute offers consulting, specializing in information retrieval and analysis, competitive intelligence, technology assessment, market research and information resources development/publishing concerning biotechnology and pharmaceutical products, research, development, technologies, patents/technology transfer, marketing and public affairs. See Mr. Rader's bio and full resume.
Contact information:

Ronald A. Rader
President
Biotechnology Information Institute
1700 Rockville Pike, Suite 400
Rockville, MD 20852
Phone: 301-424-0255
E-mail: biotech@bioinfo.com
[Phone is the most reliable method. With public Web sites, I receive loads of spam daily]